Concepedia

Thomas M. O’Dorisio

TM

Statistics

Publications

262

Citations

16.9K

H-Index

64

Active since

1973

Affiliations

The Ohio State University(Current)

University of Iowa

Ohio State University Hospital

Thomas M. O’Dorisio is an author at The Ohio State University specializing in medicine, pharmacology, and pathology.

ORCID

Top concepts

Publications per year

1973–2023

262

Publications

262

Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors

Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin et al. · New England Journal of Medicine · 2017 · 3K citations · Full text

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

James C. Yao, Catherine Lombard‐Bohas, Éric Baudin et al. · Journal of Clinical Oncology · 2009 · 648 citations · Full text

, , +15

Recommended Guidelines for the Treatment of Cancer Treatment-Induced Diarrhea

Al B. Benson, Jaffer A. Ajani, Robert B. Catalano et al. · Journal of Clinical Oncology · 2004 · 622 citations

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

Dik J. Kwekkeboom, Jan Mueller‐Brand, Giovanni Paganelli et al. · PubMed · 2005 · 375 citations

, , +15

<sup>90</sup>Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide

David Bushnell, Thomas M. O’Dorisio, M. Sue O’Dorisio et al. · Journal of Clinical Oncology · 2010 · 303 citations · Full text

Rows per page

1–5 of 262